SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2bnh'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1DMY_A_AZMA400_1
(MURINE CARBONIC
ANHYDRASE V)
2bnh RIBONUCLEASE
INHIBITOR

(Sus
scrofa)
5 / 11 HIS A  69
VAL A  68
LEU A  92
LEU A 100
THR A 103
None
1.11A 1dmyA-2bnhA:
undetectable
1dmyA-2bnhA:
18.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1LHU_A_ESTA301_1
(SEX HORMONE-BINDING
GLOBULIN)
2bnh RIBONUCLEASE
INHIBITOR

(Sus
scrofa)
5 / 12 SER A 302
GLY A 295
ASN A 289
LEU A 313
LEU A 303
None
1.29A 1lhuA-2bnhA:
undetectable
1lhuA-2bnhA:
19.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1LHU_A_ESTA301_1
(SEX HORMONE-BINDING
GLOBULIN)
2bnh RIBONUCLEASE
INHIBITOR

(Sus
scrofa)
5 / 12 SER A 416
GLY A 409
ASN A 403
LEU A 427
LEU A 417
None
1.30A 1lhuA-2bnhA:
undetectable
1lhuA-2bnhA:
19.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MX1_B_THAB2_1
(LIVER
CARBOXYLESTERASE I)
2bnh RIBONUCLEASE
INHIBITOR

(Sus
scrofa)
5 / 11 LEU A  72
LEU A  92
LEU A 120
LEU A  85
LEU A  87
None
1.00A 1mx1B-2bnhA:
undetectable
1mx1B-2bnhA:
21.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MX1_B_THAB2_1
(LIVER
CARBOXYLESTERASE I)
2bnh RIBONUCLEASE
INHIBITOR

(Sus
scrofa)
5 / 11 VAL A 274
LEU A 258
LEU A 271
LEU A 214
LEU A 229
None
1.28A 1mx1B-2bnhA:
undetectable
1mx1B-2bnhA:
21.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MZ9_A_VDYA1002_4
(CARTILAGE OLIGOMERIC
MATRIX PROTEIN)
2bnh RIBONUCLEASE
INHIBITOR

(Sus
scrofa)
4 / 5 VAL A 328
CYH A 325
ALA A 322
CYH A 324
None
1.17A 1mz9D-2bnhA:
undetectable
1mz9D-2bnhA:
9.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1R9O_A_FLPA501_1
(CYTOCHROME P450 2C9)
2bnh RIBONUCLEASE
INHIBITOR

(Sus
scrofa)
5 / 12 VAL A 315
LEU A 271
GLY A 295
ALA A 296
LEU A 313
None
0.82A 1r9oA-2bnhA:
undetectable
1r9oA-2bnhA:
22.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1YAJ_B_BEZB12_0
(CES1 PROTEIN)
2bnh RIBONUCLEASE
INHIBITOR

(Sus
scrofa)
4 / 4 GLY A 245
SER A 251
VAL A 274
LEU A 242
None
0.93A 1yajB-2bnhA:
undetectable
1yajB-2bnhA:
22.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HC4_A_VDXA525_1
(VITAMIN D RECEPTOR)
2bnh RIBONUCLEASE
INHIBITOR

(Sus
scrofa)
5 / 12 LEU A 338
CYH A 308
VAL A 328
LEU A 320
LEU A 372
None
1.39A 2hc4A-2bnhA:
undetectable
2hc4A-2bnhA:
23.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2W8Y_B_NDRB1000_0
(PROGESTERONE
RECEPTOR)
2bnh RIBONUCLEASE
INHIBITOR

(Sus
scrofa)
5 / 12 LEU A 320
LEU A 343
ASN A 346
LEU A 372
LEU A 313
None
1.41A 2w8yB-2bnhA:
undetectable
2w8yB-2bnhA:
21.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ADX_A_IMNA2_1
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR GAMMA)
2bnh RIBONUCLEASE
INHIBITOR

(Sus
scrofa)
5 / 12 CYH A 357
GLN A 358
SER A 361
LEU A 389
LEU A 372
None
1.46A 3adxA-2bnhA:
undetectable
3adxA-2bnhA:
20.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AIA_B_SAMB206_0
(UPF0217 PROTEIN
MJ1640)
2bnh RIBONUCLEASE
INHIBITOR

(Sus
scrofa)
4 / 5 LEU A 201
GLY A 230
GLU A 145
CYH A 204
None
1.02A 3aiaA-2bnhA:
undetectable
3aiaB-2bnhA:
undetectable
3aiaA-2bnhA:
19.90
3aiaB-2bnhA:
19.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3D90_B_NOGB2001_1
(PROGESTERONE
RECEPTOR)
2bnh RIBONUCLEASE
INHIBITOR

(Sus
scrofa)
5 / 12 LEU A 395
LEU A 389
ASN A 392
LEU A 390
LEU A 400
None
1.32A 3d90B-2bnhA:
undetectable
3d90B-2bnhA:
21.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DZY_A_9CRA463_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)
2bnh RIBONUCLEASE
INHIBITOR

(Sus
scrofa)
5 / 12 ALA A 359
GLN A 358
LEU A 360
CYH A 300
LEU A 304
None
1.03A 3dzyA-2bnhA:
undetectable
3dzyA-2bnhA:
23.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JWQ_B_VIAB901_1
(CGMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE
CATALYTIC DOMAIN,
CONE CGMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE
SUBUNIT ALPHA
CHIMERA)
2bnh RIBONUCLEASE
INHIBITOR

(Sus
scrofa)
5 / 11 ASN A 346
LEU A 372
ALA A 359
VAL A 328
LEU A 303
None
1.37A 3jwqB-2bnhA:
undetectable
3jwqC-2bnhA:
undetectable
3jwqB-2bnhA:
21.89
3jwqC-2bnhA:
21.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KO0_B_TFPB202_1
(PROTEIN S100-A4)
2bnh RIBONUCLEASE
INHIBITOR

(Sus
scrofa)
3 / 3 GLU A 130
LEU A 133
ASP A 134
None
0.27A 3ko0A-2bnhA:
undetectable
3ko0A-2bnhA:
13.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KO0_S_TFPS202_2
(PROTEIN S100-A4)
2bnh RIBONUCLEASE
INHIBITOR

(Sus
scrofa)
3 / 3 GLU A 130
LEU A 133
ASP A 134
None
0.26A 3ko0T-2bnhA:
undetectable
3ko0T-2bnhA:
13.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OHT_A_1N1A1000_2
(P38A)
2bnh RIBONUCLEASE
INHIBITOR

(Sus
scrofa)
3 / 3 GLU A 294
LEU A 298
LEU A 330
None
0.62A 3ohtA-2bnhA:
undetectable
3ohtA-2bnhA:
22.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OHT_B_1N1B1000_2
(P38A)
2bnh RIBONUCLEASE
INHIBITOR

(Sus
scrofa)
3 / 3 GLU A 294
LEU A 298
LEU A 330
None
0.62A 3ohtB-2bnhA:
undetectable
3ohtB-2bnhA:
22.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4C5N_C_PXLC300_1
(PHOSPHOMETHYLPYRIMID
INE KINASE)
2bnh RIBONUCLEASE
INHIBITOR

(Sus
scrofa)
4 / 8 GLY A 295
ASP A 293
GLY A 292
VAL A 315
None
0.86A 4c5nC-2bnhA:
2.0
4c5nC-2bnhA:
20.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)
2bnh RIBONUCLEASE
INHIBITOR

(Sus
scrofa)
6 / 12 ASN A 175
LEU A 157
GLY A 205
ASN A 232
LEU A 149
ASN A 210
None
1.48A 4dc3B-2bnhA:
undetectable
4dc3B-2bnhA:
20.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FP9_A_SAMA401_0
(METHYLTRANSFERASE
NSUN4)
2bnh RIBONUCLEASE
INHIBITOR

(Sus
scrofa)
6 / 12 CYH A 382
GLY A 349
GLY A 352
ASN A 379
GLY A 409
LEU A 413
None
1.43A 4fp9A-2bnhA:
undetectable
4fp9A-2bnhA:
23.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FP9_D_SAMD401_0
(METHYLTRANSFERASE
NSUN4)
2bnh RIBONUCLEASE
INHIBITOR

(Sus
scrofa)
6 / 12 CYH A 382
GLY A 349
GLY A 352
ASN A 379
GLY A 409
LEU A 413
None
1.40A 4fp9D-2bnhA:
undetectable
4fp9D-2bnhA:
23.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FP9_F_SAMF401_0
(METHYLTRANSFERASE
NSUN4)
2bnh RIBONUCLEASE
INHIBITOR

(Sus
scrofa)
6 / 12 CYH A 382
GLY A 349
GLY A 352
ASN A 379
GLY A 409
LEU A 413
None
1.40A 4fp9F-2bnhA:
undetectable
4fp9F-2bnhA:
23.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4IKJ_A_SUZA201_1
(TRANSTHYRETIN)
2bnh RIBONUCLEASE
INHIBITOR

(Sus
scrofa)
4 / 7 LEU A 370
LEU A 395
SER A 394
THR A 365
None
1.03A 4ikjA-2bnhA:
undetectable
4ikjB-2bnhA:
undetectable
4ikjA-2bnhA:
13.36
4ikjB-2bnhA:
13.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LMN_A_EUIA503_1
(DUAL SPECIFICITY
MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE 1)
2bnh RIBONUCLEASE
INHIBITOR

(Sus
scrofa)
5 / 12 LEU A  58
LEU A  63
ILE A  43
GLY A  34
LEU A  30
None
1.00A 4lmnA-2bnhA:
undetectable
4lmnA-2bnhA:
22.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LMN_A_EUIA503_2
(DUAL SPECIFICITY
MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE 1)
2bnh RIBONUCLEASE
INHIBITOR

(Sus
scrofa)
3 / 3 ASP A  31
VAL A  27
ASN A  61
None
0.78A 4lmnA-2bnhA:
undetectable
4lmnA-2bnhA:
22.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4N09_D_ADND401_2
(ADENOSINE KINASE)
2bnh RIBONUCLEASE
INHIBITOR

(Sus
scrofa)
4 / 5 CYH A 300
LEU A 338
LEU A 370
LEU A 313
None
1.21A 4n09D-2bnhA:
undetectable
4n09D-2bnhA:
21.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4OKW_A_198A1001_2
(ANDROGEN RECEPTOR)
2bnh RIBONUCLEASE
INHIBITOR

(Sus
scrofa)
4 / 7 LEU A  92
ASN A 118
LEU A 142
LEU A  85
None
1.03A 4okwA-2bnhA:
undetectable
4okwA-2bnhA:
18.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4P65_A_IPHA101_0
(INSULIN)
2bnh RIBONUCLEASE
INHIBITOR

(Sus
scrofa)
5 / 10 CYH A  97
LEU A  92
LEU A 115
LEU A 104
LEU A  72
None
1.23A 4p65A-2bnhA:
undetectable
4p65B-2bnhA:
undetectable
4p65F-2bnhA:
undetectable
4p65H-2bnhA:
undetectable
4p65A-2bnhA:
8.42
4p65B-2bnhA:
6.59
4p65F-2bnhA:
6.59
4p65H-2bnhA:
6.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4PCL_B_SAMB301_0
(O-METHYLTRANSFERASE
FAMILY PROTEIN)
2bnh RIBONUCLEASE
INHIBITOR

(Sus
scrofa)
5 / 12 LEU A  92
GLY A 121
CYH A 147
ASN A 175
ALA A 123
None
1.40A 4pclB-2bnhA:
undetectable
4pclB-2bnhA:
17.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4RGC_A_FOLA201_0
(DIHYDROFOLATE
REDUCTASE)
2bnh RIBONUCLEASE
INHIBITOR

(Sus
scrofa)
5 / 12 ILE A 177
ALA A 152
ASP A 122
LEU A 125
LEU A 170
None
1.14A 4rgcA-2bnhA:
undetectable
4rgcA-2bnhA:
15.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WOZ_F_MN9F401_0
(N-ACETYLNEURAMINATE
LYASE)
2bnh RIBONUCLEASE
INHIBITOR

(Sus
scrofa)
4 / 5 LEU A 400
ASP A 399
LEU A 413
THR A 432
None
1.08A 4wozF-2bnhA:
undetectable
4wozH-2bnhA:
undetectable
4wozF-2bnhA:
20.13
4wozH-2bnhA:
20.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XUM_A_IMNA501_1
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR GAMMA)
2bnh RIBONUCLEASE
INHIBITOR

(Sus
scrofa)
5 / 12 CYH A 243
ILE A 263
LEU A 275
LEU A 281
LEU A 256
None
1.32A 4xumA-2bnhA:
undetectable
4xumA-2bnhA:
20.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4YIA_B_IMNB401_1
(THYROXINE-BINDING
GLOBULIN)
2bnh RIBONUCLEASE
INHIBITOR

(Sus
scrofa)
5 / 10 LEU A 398
LEU A 413
SER A 380
ASN A 403
LEU A 429
None
1.18A 4yiaA-2bnhA:
undetectable
4yiaA-2bnhA:
22.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ZAU_A_YY3A1101_1
(EPIDERMAL GROWTH
FACTOR RECEPTOR)
2bnh RIBONUCLEASE
INHIBITOR

(Sus
scrofa)
5 / 8 LEU A 185
GLY A 181
VAL A 184
ALA A 158
LEU A 161
None
1.14A 4zauA-2bnhA:
undetectable
4zauA-2bnhA:
22.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ZOW_A_CLMA500_0
(MULTIDRUG
TRANSPORTER MDFA)
2bnh RIBONUCLEASE
INHIBITOR

(Sus
scrofa)
5 / 11 LEU A 185
LEU A 115
LEU A 139
LEU A 167
LEU A 113
None
1.03A 4zowA-2bnhA:
undetectable
4zowA-2bnhA:
23.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ZOW_A_CLMA500_0
(MULTIDRUG
TRANSPORTER MDFA)
2bnh RIBONUCLEASE
INHIBITOR

(Sus
scrofa)
5 / 11 LEU A 332
LEU A 286
LEU A 310
LEU A 338
LEU A 284
None
1.04A 4zowA-2bnhA:
undetectable
4zowA-2bnhA:
23.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A06_A_SORA1342_0
(ALDOSE-ALDOSE
OXIDOREDUCTASE)
2bnh RIBONUCLEASE
INHIBITOR

(Sus
scrofa)
5 / 7 ILE A 353
CYH A 375
LYS A 347
LEU A 348
GLY A 352
None
1.32A 5a06A-2bnhA:
undetectable
5a06A-2bnhA:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A06_C_SORC1342_0
(ALDOSE-ALDOSE
OXIDOREDUCTASE)
2bnh RIBONUCLEASE
INHIBITOR

(Sus
scrofa)
5 / 7 ILE A 353
CYH A 375
LYS A 347
LEU A 348
GLY A 352
None
1.29A 5a06C-2bnhA:
undetectable
5a06C-2bnhA:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A06_E_SORE1341_0
(ALDOSE-ALDOSE
OXIDOREDUCTASE)
2bnh RIBONUCLEASE
INHIBITOR

(Sus
scrofa)
5 / 7 ILE A 353
CYH A 375
LYS A 347
LEU A 348
GLY A 352
None
1.30A 5a06E-2bnhA:
undetectable
5a06E-2bnhA:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A06_F_SORF1341_0
(ALDOSE-ALDOSE
OXIDOREDUCTASE)
2bnh RIBONUCLEASE
INHIBITOR

(Sus
scrofa)
5 / 7 ILE A 353
CYH A 375
LYS A 347
LEU A 348
GLY A 352
None
1.29A 5a06F-2bnhA:
3.1
5a06F-2bnhA:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JQ7_B_T0RB705_1
(ENVELOPE
GLYCOPROTEIN
1,ENVELOPE
GLYCOPROTEIN
1,ENVELOPE
GLYCOPROTEIN 1
ENVELOPE
GLYCOPROTEIN 2)
2bnh RIBONUCLEASE
INHIBITOR

(Sus
scrofa)
4 / 7 VAL A 315
LEU A 320
LEU A 341
LEU A 338
None
0.66A 5jq7A-2bnhA:
undetectable
5jq7A-2bnhA:
19.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Z6M_A_FOLA201_0
(DIHYDROFOLATE
REDUCTASE)
2bnh RIBONUCLEASE
INHIBITOR

(Sus
scrofa)
5 / 11 ILE A 177
ALA A 152
ASP A 122
LEU A 125
LEU A 170
None
1.06A 5z6mA-2bnhA:
undetectable
5z6mA-2bnhA:
15.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6BP4_A_SAMA505_1
(HISTONE-LYSINE
N-METHYLTRANSFERASE,
H3 LYSINE-9 SPECIFIC)
2bnh RIBONUCLEASE
INHIBITOR

(Sus
scrofa)
3 / 3 ILE A 177
ASN A 232
CYH A 211
None
0.75A 6bp4A-2bnhA:
undetectable
6bp4A-2bnhA:
21.20